Admiraal de Ruijter ziekenhuis
- Address
- 's-Gravenpolderseweg 114, 4462RA Goes, The Netherlands
Cardiovascular Diseases
At Admiraal de Ruijter ziekenhuis, the internal medicine department is conducting research aimed at improving outcomes for patients with severe kidney impairment and heart failure. The trial evaluates whether Dapagliflozin can lower the risk of kidney failure, hospitalization for heart failure, and overall mortality.
- Evaluation of renal and cardiac composite endpoints
- Impact of SGLT2 inhibition in advanced chronic kidney disease
- Assessment of patient survival and quality of life
The study involves two investigators and reflects the hospital’s commitment to advancing cardiovascular and renal care in the Netherlands.
Neoplasms
The same site is also exploring treatment strategies for multiple myeloma within its internal medicine division. Researchers compare continuous therapy with daratumumab‑lenalidomide‑dexamethasone against a planned treatment‑free interval to understand effects on event‑free and progression‑free survival.
- Therapeutic sequencing in newly diagnosed myeloma
- Evaluation of treatment discontinuation safety
- Measurement of progression‑free outcomes
With two dedicated investigators, this work highlights the hospital’s focus on innovative cancer care alongside its cardiovascular programs.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 271 other sites in The Netherlands
Therapeutic Area Benchmark — The Netherlands
Select a therapeutic area to compare against other sites in The Netherlands.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: The Netherlands
Market Share
Country: The Netherlands
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Admiraal de Ruijter ziekenhuis
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients with Severe Chronic Kidney Disease: A Randomized Controlled Trial | Universitair Medisch Centrum Groningen | Phase III | Recruiting | Nov 2022 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dapagliflozin | 1 | Unknown | 2022-11-08 | 2022-11-08 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.